Investing Profile
Michael Rome
VCInvestor
Managing Director at Foresite Capital
foresitecapital.com/people/mi...Los Angeles, California
Your Intro Paths to Michael Rome
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Michael is a member of
University of California, Los Angeles Network
258 CONNECTIONS
UCLA Network
182 CONNECTIONS
Caltech Network
65 CONNECTIONS
UCLA Fielding School of Public Health Network
38 CONNECTIONS
University of California, Los Angeles Network
28 CONNECTIONS
Find Michael Rome on
cbCurrent Investing Position
Foresite Capital Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
15
Current Fund Size
$668M
Michael Rome is on these Sector & Stage Rankings
Consumer Health (Series B)BioTech (Series B)Consumer Health (Series A)BioTech (Seed)Consumer Health (Seed)BioTech (Series A)Health & Hospital Services (Series B)Health IT (Series A)Los Angeles / Southern CaliforniaHealth & Hospital Services (Series A)Digital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)
Michael Rome's Investments On Record (9)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Khartis Therapeutics | Series BAug 2026$50M Series AJan 2024$45M | $95M |
RayThera | Series AApr 2025$110M | $110M |
Alumis | Series CMar 2024$260M Series AMay 2021$70M | $330M |
Remix Therapeutics | Series UnknownJan 2024$60M Series BMay 2022$70M Series ADec 2020$65M | $210M |
CG Oncology | Series FAug 2023$110M | $110M |
XinThera | Series BAug 2021$50M | $50M |
Theseus Pharmaceuticals | Series BApr 2021$100M | $100M |
Kinnate Biopharma | Series CAug 2020$98M Series BDec 2019$75M Series AApr 2018$22M | $200M |
Michael Rome's Experience
Work Student Impact Program for Prostate Cancer TreatmentPresent
Lab Assistant and Researcher University of California, Los AngelesPresent
Lab Assistant and Researcher UCLA Fielding School of Public HealthPresent
Research Associate in Microbiology University of California, Los AngelesPresent
Graduate Researcher in Biochemistry California Institute of TechnologyPresent
Managing Director Foresite CapitalPresent
Board Observer Turning Point TherapeuticsPresent
Board Member Kinnate Biopharma Inc.Present
Director Foresite Capital ManagementPresent
Board Member Remix TherapeuticsPresent
Board Member XinThera Inc.Present
Board Observer Affinivax Inc.Present
Board Member and Observer AlumisPresent
Board Observer AffinivaxPresent
Board Member Avenzo TherapeuticsPresent
Board Observer CG OncologyPresent
Board Member RayTheraPresent
Office Assistant Impact Program for Prostate Cancer TreatmentPresent
Physical Sciences Tutor Los Angeles Valley CollegePresent
Lab Assistant and Researcher UCLAPresent
Research Associate in Microbiology UCLAPresent
Graduate Researcher in Biochemistry CaltechPresent
Scientist and Senior Scientist Vault PharmaPresent
Analyst DAFNA Capital Management, LLCPresent
Senior Analyst Foresite Capital ManagementPresent
Michael Rome's Education
California Institute of Technology Doctor of Philosophy (Ph.D.) Biochemistry, Biophysics and Molecular Biology
University of California, Los Angeles BS Molecular, Cellular and Developmental Biology
UCLA BS Molecular, Cellular and Developmental Biology
Caltech Doctor of Philosophy (Ph.D.) Biochemistry
University of California, Los Angeles BS Molecular, Cellular and Developmental Biology
Investors who invest with Michael Rome
Sign in with Google →Scouts & Angels Affiliated With Michael Rome
Sign in with Google →